Tara Homer

Tara Homer

Newcastle University

H-index: 11

Europe-United Kingdom

About Tara Homer

Tara Homer, With an exceptional h-index of 11 and a recent h-index of 10 (since 2020), a distinguished researcher at Newcastle University, specializes in the field of Health Economics, Economic Evaluation, Health Technology Assessment.

His recent articles reflect a diverse array of research interests and contributions to the field:

Qualitative research integrated within Trials Recruitment Intervention study

Economic evaluation

Qualitative process evaluation

Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT.

Is primary trabeculectomy cost-effective for patients with advanced primary open angle glaucoma? Results from the Treatment of Advanced Glaucoma Study economic model

Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer …

Evaluating primary treatment for people presenting with advanced glaucoma: 5-year results of the Treatment of Advanced Glaucoma Study

Abstract PO2-23-05: Practice patterns and outcomes in the ongoing neoadjuvant ATNEC trial: node marking, response to NACT and breast conservation rates

Tara Homer Information

University

Position

Senior Research Associate

Citations(all)

539

Citations(since 2020)

439

Cited By

205

hIndex(all)

11

hIndex(since 2020)

10

i10Index(all)

12

i10Index(since 2020)

10

Email

University Profile Page

Google Scholar

Tara Homer Skills & Research Interests

Health Economics

Economic Evaluation

Health Technology Assessment

Top articles of Tara Homer

Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT.

Health Technology Assessment (Winchester, England)

2024/3

Is primary trabeculectomy cost-effective for patients with advanced primary open angle glaucoma? Results from the Treatment of Advanced Glaucoma Study economic model

British Journal of Ophthalmology

2024/2/9

Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer …

PharmacoEconomics

2024/2

Abstract PO2-23-05: Practice patterns and outcomes in the ongoing neoadjuvant ATNEC trial: node marking, response to NACT and breast conservation rates

Cancer Research

2024/5/2

Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open …

BMJ open

2024/4/1

Tonsillectomy compared with conservative management in patients over 16 years with recurrent sore throat: the NATTINA RCT and economic evaluation

Health Technology Assessment

2023

Protocol: Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial …

BMJ Open

2023

The NAtional Trial of Tonsillectomy IN Adults: a clinical and cost-effectiveness RCT (NATTINA)

Health Technology Assessment

2023

Tables and histograms showing 6-and 18-month postal return and 12-and 24-month visit compliance

2023/12

Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial

bmj

2023/10/18

Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma

British Journal of Ophthalmology

2023/10/1

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying …

BMJ open

2023/8/1

Conservative management versus tonsillectomy in adults with recurrent acute tonsillitis in the UK (NATTINA): a multicentre, open-label, randomised controlled trial

The Lancet

2023/6/17

Abstract OT1-09-02: ATNEC: A multicentre, randomized trial investigating whether axillary treatment can be avoided in T1-3N1M0 breast cancer patients with no residual cancer in …

Cancer Research

2023/3/1

See List of Professors in Tara Homer University(Newcastle University)